Evolution of clinical, histological and serological features in a Primary Sjὄgren´s Syndrome cohort and the limitations of the current classification criteria.
Carmen Magdalena Gamboa-Alonso, David Vega-Morales, Janett Luzmila Riega-Torres, Brenda Roxana Vázquez-Fuentes, Luis Ángel Ceceñas-Falcón, Gabriel Figueroa-Parra, Jazzia Emily Díaz-Angulo, Dionicio Ángel Galarza-Delgado
{"title":"Evolution of clinical, histological and serological features in a Primary Sjὄgren´s Syndrome cohort and the limitations of the current classification criteria.","authors":"Carmen Magdalena Gamboa-Alonso, David Vega-Morales, Janett Luzmila Riega-Torres, Brenda Roxana Vázquez-Fuentes, Luis Ángel Ceceñas-Falcón, Gabriel Figueroa-Parra, Jazzia Emily Díaz-Angulo, Dionicio Ángel Galarza-Delgado","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The classification and/or diagnosis of Primary Sjögren's Syndrome (PSS) requires a multidimensional approach. Although age and the duration of sicca symptoms can affect the clinical, serological and histological features found at initial evaluation, these are not considered when using classification criteria as a guide for PSS diagnosis. Our study aimed to explore if there is any relationship between the duration of symptoms and clinical, histopathological and serological findings.</p><p><strong>Methods: </strong>An observational, retrospective study was performed. All the evaluated subjects were part of the \"sicca cohort\". Patients' clinical, serological and histological characteristics were assessed according to the duration of symptoms. A Receiving Operator Characteristic (ROC) curve was performed to establish the duration of symptoms (months) that predicted a PSS diagnosis. Binary regression models and odds ratios were used to evaluate the association between the duration of symptoms and the clinical, serological, and histopathological profiles.</p><p><strong>Results: </strong>One hundred and sixteen patients were included; 97(83.62%) fulfilled PSS criteria. Of the 116 patients, thirty-six (31.03%) had < 15 months presenting with sicca symptoms when receiving a diagnostic approach. A duration of symptoms >15 months was associated with an altered Schirmer test (OR 2.76; 95% CI 1.15-6.61, P=0.02), low salivary flow rate (OR 3.5; 95% CI 1.34-9.13, P=0.01), ≥1 foci score (OR 1.21; 95% CI 1-1.45, P=0.04), ocular (OR 7.8; 95% CI 1.49-40.81, P=0.02) and severe oral symptoms (OR 2.61; 95% CI 1.16-5.87, P=0.02).</p><p><strong>Conclusion: </strong>The time of evolution of symptoms plays a fundamental role in the clinical, histological and serological profiles in PSS.</p>","PeriodicalId":7229,"journal":{"name":"Acta reumatologica portuguesa","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta reumatologica portuguesa","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The classification and/or diagnosis of Primary Sjögren's Syndrome (PSS) requires a multidimensional approach. Although age and the duration of sicca symptoms can affect the clinical, serological and histological features found at initial evaluation, these are not considered when using classification criteria as a guide for PSS diagnosis. Our study aimed to explore if there is any relationship between the duration of symptoms and clinical, histopathological and serological findings.
Methods: An observational, retrospective study was performed. All the evaluated subjects were part of the "sicca cohort". Patients' clinical, serological and histological characteristics were assessed according to the duration of symptoms. A Receiving Operator Characteristic (ROC) curve was performed to establish the duration of symptoms (months) that predicted a PSS diagnosis. Binary regression models and odds ratios were used to evaluate the association between the duration of symptoms and the clinical, serological, and histopathological profiles.
Results: One hundred and sixteen patients were included; 97(83.62%) fulfilled PSS criteria. Of the 116 patients, thirty-six (31.03%) had < 15 months presenting with sicca symptoms when receiving a diagnostic approach. A duration of symptoms >15 months was associated with an altered Schirmer test (OR 2.76; 95% CI 1.15-6.61, P=0.02), low salivary flow rate (OR 3.5; 95% CI 1.34-9.13, P=0.01), ≥1 foci score (OR 1.21; 95% CI 1-1.45, P=0.04), ocular (OR 7.8; 95% CI 1.49-40.81, P=0.02) and severe oral symptoms (OR 2.61; 95% CI 1.16-5.87, P=0.02).
Conclusion: The time of evolution of symptoms plays a fundamental role in the clinical, histological and serological profiles in PSS.
目的:原发性Sjögren综合征(PSS)的分类和/或诊断需要多维度的方法。虽然年龄和干燥症状持续时间会影响初步评估时发现的临床、血清学和组织学特征,但在使用分类标准作为PSS诊断指南时,这些因素并未被考虑在内。我们的研究旨在探讨症状持续时间与临床、组织病理学和血清学结果之间是否存在任何关系。方法:采用观察性、回顾性研究。所有被评估对象均为“sicca队列”的一部分。根据症状持续时间评估患者的临床、血清学和组织学特征。采用接收操作者特征(ROC)曲线建立预测PSS诊断的症状持续时间(月)。使用二元回归模型和比值比来评估症状持续时间与临床、血清学和组织病理学特征之间的关系。结果:共纳入116例患者;97例(83.62%)符合PSS标准。在116例患者中,36例(31.03%)在接受诊断方法时出现风干症状< 15个月。症状持续时间>15个月与Schirmer试验改变相关(OR 2.76;95% CI 1.15-6.61, P=0.02),低唾液流率(OR 3.5;95% CI 1.34-9.13, P=0.01),≥1个焦点评分(OR 1.21;95% CI 1-1.45, P=0.04),眼部(OR 7.8;95% CI 1.49-40.81, P=0.02)和严重口腔症状(OR 2.61;95% ci 1.16-5.87, p =0.02)。结论:症状演变时间在PSS的临床、组织学和血清学特征中起着重要作用。
期刊介绍:
Acta Reumatólogica Portuguesa is a scientific peer reviewed journal covering all aspects of rheumatic diseases and related to Rheumatology. The journal publishes original articles, reviews, clinical cases, images in rheumatology, letters to the editor and clinical teaching (e.g. guidelines and clinical protocols).
Published since 1973, Acta Reumatológica Portuguesa is the official scientific publication of the Portuguese Society of Rheumatology, a non-profit organization that promotes the knowledge and investigation of rheumatic diseases and the development of Rheumatology.